Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
| Revenue (Most Recent Fiscal Year) | $119.48M |
| Net Income (Most Recent Fiscal Year) | $-81.65M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.54 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.50 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -67.74% |
| Net Margin (Trailing 12 Months) | -68.34% |
| Return on Equity (Trailing 12 Months) | -55.65% |
| Return on Assets (Trailing 12 Months) | -28.64% |
| Current Ratio (Most Recent Fiscal Quarter) | 6.67 |
| Quick Ratio (Most Recent Fiscal Quarter) | 5.77 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.76 |
| Inventory Turnover (Trailing 12 Months) | 1.42 |
| Book Value per Share (Most Recent Fiscal Quarter) | $6.93 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-1.07 |
| Earnings per Share (Most Recent Fiscal Year) | $-5.33 |
| Diluted Earnings per Share (Trailing 12 Months) | $-6.79 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 18.31M |
| Free Float | 17.87M |
| Market Capitalization | $64.64M |
| Average Volume (Last 20 Days) | 0.36M |
| Beta (Past 60 Months) | 2.08 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.40% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |